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Incidence and risk factors for pacemaker implantation following
aortic valve replacement
Abstract
Our aim was to identify the predictive factors for permanent pacemaker (PM) implantation in patients
undergoing isolated aortic valve replacement (AVR). A total of 3534 patients received an AVR between
January 1990 and December 2003 in our institution. Permanent PM implantation was performed in 234
(6.6%) patients, over median time of three days (range one to 24 days). This patient population was
compared to a random sample of 191 patients undergoing AVR without permanent PM implantation.
The overall mean age was 63.5 years (±14.2) and 261 patients (62%) were male. Univariate and
multivariate logistic regression analysis of pre- and perioperative data were performed. Overall the
30 days mortality was 4.2% (10/234) in patients with PM and 1% (2/191) in the control group
(P=0.046). Patients with PMs were older (P<0.001), had more additional coronary artery bypass grafting
(CABG) surgery or mitral valve replacement (MVR) (P<0.001), complete right bundle branch block
(RBBB) prior to surgery, and more frequently underwent re-operations compared to patients without
PMs (P<0.001). The multivariate logistic regression model with PM implantation as the dependent
variable demonstrated that older age was not independently associated with PM implantation. As
independent predictors concomitant severe mitral valve insufficiency, CABG, subaortic stenosis (SAS)
or re-do operations were identified.
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Abstract
Our aim was to identify the predictive factors for permanent pacemaker (PM) implantation in patients undergoing isolated aortic valve
replacement (AVR). A total of 3534 patients received an AVR between January 1990 and December 2003 in our institution. Permanent PM
implantation was performed in 234 (6.6%) patients, over median time of three days (range one to 24 days). This patient population was
compared to a random sample of 191 patients undergoing AVR without permanent PM implantation. The overall mean age was 63.5 years
("14.2) and 261 patients (62%) were male. Univariate and multivariate logistic regression analysis of pre- and perioperative data were
performed. Overall the 30 days mortality was 4.2% (10y234) in patients with PM and 1% (2y191) in the control group (Ps0.046). Patients
with PMs were older (P-0.001), had more additional coronary artery bypass grafting (CABG) surgery or mitral valve replacement (MVR)
(P-0.001), complete right bundle branch block (RBBB) prior to surgery, and more frequently underwent re-operations compared to patients
without PMs (P-0.001). The multivariate logistic regression model with PM implantation as the dependent variable demonstrated that
older age was not independently associated with PM implantation. As independent predictors concomitant severe mitral valve insufficiency,
CABG, subaortic stenosis (SAS) or re-do operations were identified.
 2010 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Aortic valvular stenosis and regurgitation are associated
with abnormalities of conduction, including higher degrees
of atrioventricular (AV) block. Aortic valve replacement
(AVR) can result in the development of further conduction
abnormalities, which may be associated with an increased
risk of sudden death w1x.
The association of intraventricular conduction disorders and
aortic valve surgery is frequently seen as a transient episode.
However, definitive conduction lesions, which result in a per-
manent pacemaker (PM) implantation, are reported to occur
in between 2% and 7% of patients undergoing AVR w2, 3x.
Since the first description was made of intraventricular
conduction defects as a complication of AVR in 1972, there
has been a remarkably wide variation in the literature in
regard to timing of PM implantation following AVR. The
recommended waiting period ranges from three to 21 days
after the onset of a high-degree AV block prior to a
permanent PM implantation w3, 4x. Mechanical trauma to
the conduction system in the vicinity of the aortic valve is
thought to be the most common contributing factor for a
*Corresponding author. Tel.: q41-44-466-11-79; fax: q41-44-466-27-45.
E-mail address: Ulrich.Schurr@triemli.stzh.ch (U.P. Schurr).
permanent PM implantation following AVR. Additionally
surgical procedures, such as myectomy for hypertrophic
obstructive cardiomyopathy, or the repair of a concomitant
ventricular septal defect (VSD) w4x were postulated as
predictive factors for PM implantation. However, risk fac-
tors, such as patient age, preoperative conduction distur-
bances, preoperative medication, strong calcified aortic
root or extracorporeal circulation (ECC) time and balance,
are less well studied as potential contributing risk factors
for a PM implantation after AVR.
Identifying risk factors responsible for developing conduc-
tion system abnormalities that are likely to require post-
operative permanent PM would be of substantial clinical
benefit to facilitate the planning of postoperative care. In
the presented study, we sought to identify clinical criteria
that might predict the need for early postoperative per-
manent PM implantation following AVR.
2. Materials and methods
2.1. Patient population
Between January 1990 and December 2003, a total of
3534 patients underwent AVR in the Department of Cardio-
vascular Surgery at the University Hospital of Zurich.
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Table 1. Characteristics of 425 patients undergoing aortic valve replacement
PM implantation Control group (no PM – implantation) P-value
n (234) MeanyS.D. n (191) MeanyS.D.
Male gender 139 123 ns
Female gender 94 68 ns
Days to PM implantation 1–24 4.4"3.8 0
Age 19–84 66"14 20–88 60.2"13.9 0.001
Valve size (mm) 18–31 23"2.2 12–32 23.5"2.4 0.034
Valve orifice area (cm )2 0.3–1.5 0.68"0.2 0.3–1.2 0.7"0.9 ns
Mean delta – P (mmHg) 14–96 44.6"12.2 10–119 59"18.6 0.001
EF (%) 20–85 53.6"13.5 15–90 57"13.4 0.002
Intraventricular conduction disorders
Complete LBBB 19 8.1% 9 4.7% ns
Partial LBBB 5 2.1% 1 0.52% ns
Complete RBBB 25 10.6% 7 3.6% 0.006
Partial RBBB 4 1.7% 1 0.52% ns
PM, pacemaker; S.D., standard deviation; EF, ejection fraction; LBBB, left bundle branch block; RBBB, right bundle branch block; ns, not significant.
Table 2. Preoperative aortic valve pathology and associated surgical
procedures
PM Control group P-value
implantation (no PM –
implantation)
n (234) % n (191) %
AV stenosis 167 71.3 145 75.9 ns
AV regurgitation 77 32.9 51 26.7 ns
AV infection 22 9.4 15 7.8 ns
AV redo 35 14.9 7 3.6 0.001
SAS resection 34 14.5 11 5.7 0.004
Cooley patch 15 6.4 8 4.1 ns
Homograft 13 5.5 18 9.4 ns
Biological valve 91 39 53 27.7 ns
Mechanical valve 115 49 118 61.7 ns
Composite graft 14 5.9 2 1.05 ns
Isolated AVR 73 31 155 81 0.001
AVRqMVR 13 5.5 2 1.02 0.001
AVRqMV repair 11 4.7 3 1.5 0.001
AVRqCABG 99 42.3 15 7.8 0.001
AVRqVSD closure 6 2.5 0
AVRqASD closure 11 4.7 0
AVRqprevious MVR 2 0.8 0
AVRqprevious MV repair 4 1.7 0
AVRqpreoperative MI 29 12.3 10 5.2 0.011
AVRqpHTN 54 23.1 44 23.05 ns
PM, pacemaker; AV, atrioventricular; SAS, subaortic stenosis; AVR, aortic
valve replacement; MVR, mitral valve replacement; MV, mitral valve; CABG,
coronary artery bypass grafting; VSD, ventricular septal defect; ASD, atrial
septal defect; MI, myocardial infarction; pHTN, pulmonal hypertension.
Permanent PM implantation, due to a high degree of AV
block (AV block II–III), was performed in 234 patients (6.5%)
during their hospital stay. As a control group a random
sample of 191 patients undergoing AVR without PM implan-
tation was chosen. Consequently, the study population
consisted of 425 patients (262 were male with a mean age
of 65 years). Exclusion criteria were the presence of a
preoperative permanent PM and evidence of AV block in
preoperative ECG.
The major indications for AVR were predominant valvular
stenosis in both investigations’ subpopulations, 167 (71.5%,
167y234) in PM and 145 (75.9%, 145y191) in control group.
Comprehensive perioperative data were collected from the
database and from surgical or anesthetic notes. Mechanical
prosthesis was implanted in 115 (49%) in the PM group, in
control group 118 (61.7%) patients received a mechanical
valve. Baseline demographic details are shown in Tables 1
and 2.
2.2. Surgical technique
Implantation technique was identical in all patients during
the study period. AVR was performed on ECC with a
moderate hypothermia (26–28 8C) and a mean pressure of
50–70 mmHg. Myocardial protection was achieved by ret-
rograde cold blood cardioplegia. Repetitive dosages were
given every 10 min. The left ventricle (LV) was vented
through the right superior pulmonary vein. The valve pros-
thesis was implanted with single pledged stitches.
Postoperatively, a 12 lead ECG was recorded on a daily
basis until the fourth postoperative day and then every
second day until discharge of the patient.
Operative mortality was defined as death occurring within
30 days after the operation. The studied parameters were
divided in pre-, intra-, and postoperative data blocks and
are shown by Tables 2–4.
2.3. Statistical analysis
Standard demographic and clinical variables were record-
ed on standardized data forms. Statistical analysis was
performed using JMP IN (SAS Campus Drive, Cary, NC
27513, USA; version 5.1). Univariate relations of all peri-
operative factors requiring PM implantation after AVR were
analysed by using x -test, Fisher’s exact test and the Mann–2
Whitney test. To identify significant differences in numeri-
cal variables the Mann–Whitney test was used. The x -test2
and Fisher’s exact test were performed to analyse categor-
ical variables. Differences were considered significant at a
P-value of less than 0.05. Combinations of risk factors were
evaluated with multiple logistic regression models. Factors
showing a value of P-0.05 in univariate analyses were
entered into multivariate logistic regression analysis.
3. Results
A permanent PM was implanted in 234 (6.5%) out of 3534
patients, the mean period of implantation was 4.4"3.8
days (range one to 24 days). Indications for PM implanta-
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Table 3. Intraoperative variables in both investigated patient populations
PM implantation Control group (no PM – implantation P-value
n (234) MeanyS.D. n (191) MeanyS.D.
ECC balance 2039"1302 1730"1681 0.003
ECC time (minute) 137"63.4 101"31.8 0.001
Aortic cross-clamp time (minute) 80.5"37.8 61"62.6 0.001
Systemic hypothermia (8C) 26.8"3.9 28"3.7 0.033
Atrioventricular conduction disorders II
AV block 2 (AVB) 8 3.4% 5 2.6% ns
AV block 3 88 38.2% 10 5.2% 0.001
Intraventricular conduction disorders
LBBB 22 9.4% 13 6.8% ns
RBBB 30 12.8% 7 3.6% 0.001
Intraoperative valve assessment
Strong calcified aortic annulus 123 52.5% 115 60.2% ns
Moderate calcified aortic annulus 53 22.6% 36 18.8% ns
Calcified mitral annulus 36 15.4% 40 20.1% ns
PM, pacemaker; S.D., standard deviation; ECC, extracorporeal circulation; LBBB, left bundle branch block; RBBB, right bundle branch block.
Table 4. Comparison of postoperative data in pacemaker implantation and control group
PM implantation Control group (no PM – implantation) P-value
n (234) MeanyS.D.y% n (191) MeanyS.D.y%
EF % postoperative 20–80 51.3"10.6 20–80 54"10.4 0.001
ICU (h) 91.5"72 34"27 0.001
Extubation (h) 34.4"59 11.2"12.3 0.001
AV block II 29 12.4% 1 0.5%
AV block III 99 42.3% 1 0.5%
LBBB 66 28.2% 28 14.6% ns
Partial LBBB 7 2.9% 4 2.08% ns
Complete RBBB 34 14.5% 14 7.3% 0.021
Partial RBBB 4 1.7% 4 2.08% ns
Slow junctional rhythm 9 3.8%
Onset of AV block IIyIII at POD 1–9 1.96"1.21
Transient postoperative AV block IIyIII 6 3.1%
PM, pacemaker; S.D., standard deviation; EF, ejection fraction; ICU, intensive care unit; AV block, atrioventricular block; LBBB, left bundle branch block; RBBB,
right bundle branch block; POD, postoperative day.
Table 5. In-hospital complications following aortic valve procedure
PM Control group P-value
implantation (no PM –
implantation)
n (234) % n (191) %
Myocardial infarction 4 1.7 2 1.1 ns
Neurological disorders 11 4.7 4 2.1 ns
Bleeding (rethoracotomy) 22 9.4 8 4.1 0.03
Sternal infection 9 3.8 3 1.5 ns
Pulmonary infection 15 6.4 6 3.1 ns
Renal complication 8 3.4 2 1.1 ns
In-hospital mortality 10 4.2 2 1.05 0.046
PM, pacemaker.
tions were as follows, 227 of 234 (97%) developed a higher
degree of AV block, 99 patients (42%) developed a complete
or high degree AV block intraoperatively. During hospitalis-
ation 128 patients (55%) also developed higher AV of higher
degree. The onset for the postoperative AV block in this
patient population appeared in an average time of 1.96
days (range: one to nine days). Persistent symptomatic
sinus bradycardia and junctional rhythms was found in
seven patients (3.8%) this was also an indication for per-
manent PM implantation (two of these patients underwent
a superior trans-septal approach to the mitral valve). In
this investigation group (PM implantation) 140 (59.8%)
patients received an additional surgical procedure, such as
coronary artery bypass grafting (CABG) (99y234), mitral
valve replacement (MVR) (13y234) and repair (11y234)
(Table 2).
In the control group, the onset of transient AV block was
found to occur between postoperative days two to five
(average of 3.8 days) in six patients.
Patients with PM implantation were found to be older
(P-0.001) and to have had a myocardial infarction (MI)
(P-0.01) and a complete right bundle branch block (RBBB)
(P-0.006) more frequently prior to aortic valve surgery.
Furthermore, patients in the PM group underwent more
additional cardiac procedures, such as CABG surgery
(P-0.0001), MVR (P-0.001), subaortic stenosis (SAS)
resection (P-0.001), or re-operations (P-0.001) when
compared to patients without PM implantation (Tables
2–4).
The overall in-hospital mortality rate was 4.2% (10y234)
for patient group undergoing PM implantation, 1% (2y191)
in the control group (Ps0.046) (Tables 5 and 6). Mortality
for isolated AVR with PM implantation was 1.4% (1y73).
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Table 6. Multivariate predictors of permanent PM implantation following AVR. Univariate factors showing a P-0.05 were entered into multivariate logistic
regression analysis
n (234) n (191) P-value OR 95% CI
RBBB 25 7 0.006 3.40 1.21; 9.5
Severe MV insufficiency 46 7 0.001 4.34 2.37; 7.93
Associated procedures: CABG 99 15 0.0001 3 1.78; 5.06
Aortic annulus seize 19–21 72 42 0.0441 1.94 1.02; 3.68
ECC time 137"63.4 101"31.8 0.001 1.01 1.0; 1.02
Redo 35 7 0.001 7.50 2.7; 20.4
SAS resection 34 11 0.004 3.80 1.55; 9.3
PM, pacemaker; AVR, aortic valve replacement; OR, odds ratio; CI, confidence interval; RBBB, right bundle branch block; MV, mitral valve; CABG, coronary
artery bypass grafting; ECC, extracorporeal circulation; SAS, subaortic stenosis.
The multivariate logistic regression model with PM implan-
tation as the dependent variable demonstrated that older
age was not independently associated with PM implantation
(Table 6).
Furthermore, a small aortic annular size, a prolonged ECC
duration, and a higher ECC balance were found to present
minor additional risk factors for PM implantation following
AVR (Tables 1 and 3).
4. Discussion
Rhythm disturbances and transient conduction disorders
are frequently seen following cardiac procedures, and most
of them present a sinus node dysfunction, various fascicular
blocks, or higher AV blocks. Fortunately, the majority are
self-limited and vanish before hospital discharge of the
patient. A few, however, are permanent and result in the
implantation of a permanent PM w5–8x.
Following aortic valve surgery, the onset of bradycardia is
usually caused by a persistent, complete AV block, which
requires permanent pacing in between 2% and 7% of
patients w9–11x. Similar to the data in the recent literature
in our study population series the incidence of the perma-
nent PM implantation was 6.5%. This includes the patients
undergoing AVR associated with surgical procedures, such
as CABG and additional valve replacement andyor recon-
structions. Additionally in the patient subpopulation where
only isolated AVR was performed, 2% (73y3534) of them
received a permanent PM implantation. These data are
compared to the recent literature, where the incidence of
the PM implantation following isolated ARV ranges between
3.2% and 4.6% w3, 8, 12x.
A more detailed analysis of our results revealed that of
the additional surgical procedures, such as MVR, SAS resec-
tion, VSD closure might be postulated as predicted factors
for the occurrence of postoperative AV conduction distur-
bances. These findings are not surprising given the well-
recognized association between surgical manipulations at
the fibrous skeleton of the aortic valve and the immediate
anatomical vicinity of the AV node and the proximal con-
duction bundle. The necessity for de-calcification of a
heavily calcified aortic annulus is chiefly assumed to be a
major contributing factor for the occurrence of a partial
or complete AV block postoperatively w2, 3, 8x. Surprisingly,
we were unable to find a significant correlation between
the severity of aortic annular calcifications and the occur-
rence of a permanent PM implantation, as well as the
occurrence of a postoperative left bundle branch block
(LBBB). However, the assessment of the degree of valvular
calcifications was subjective and based on the visual
impressions of the surgeon. Although the finding of preop-
erative RBBB as a significant risk factor for post-AVR PM
implantation is surprising, its cause is not clear.
Further surgery-related factors, which significantly
increased the risk for PM implantation, are the performance
of concomitant CABG, mitral valve surgery and re-opera-
tions. These findings are also reflected by the fact, that a
longer ECC time and balance were revealed as risk factors
for a PM implantation following AVR. AVR was performed
with moderate haemodilution and myocardial protection,
which was achieved as retrograde cold blood cardioplegia.
In the literature some evidence exists to suggest that blood
cardioplegia may increase the risk of permanent PM implan-
tation w13x. Additionally in the literature it was suggested
that that a significant factor in the pathogenesis of con-
duction blocks is cold-related injury w14x.
Further the retrograde cardioplegia protects only the left
coronary artery supply systems, in case of right origin of
the atrio-ventricular bundle artery, this is not protected
adequately during the surgical procedure, and as thus may
be also an origin of postoperative conduction disturbance.
The occurrence of ischaemic injury to the conduction
system and the development of myocardial oedema follow-
ing prolonged periods of ECC might explain these findings
w15x.
The analysis of the preoperative risk factors showed that
older age, MI, and a complete RBBB prior to AVR present
risk factors for a postoperative PM implantation and were
confirmed by multivariate analysis. The findings of the
preoperative significance of severe mitral valve insufficien-
cy as a predictive factor is reflected in the additional
procedure on the mitral valve that was performed parallel
to the AVR. However, age did not continue to present a risk
factor for PM implantation following AVR when undergoing
multivariate analysis and this finding stands in contrast to
several reports w4, 10, 13x.
An important aspect of postoperative PM implantation
after AVR is in the timing of the implantation procedure in
order to reduce periods of intensive care unit (ICU) and
hospital stays and the subsequent costs. Remarkable is the
wide variation of this timing reported in the literature,
which ranges from three to 21 days and does not allow for
a clear answer to the question of how long one should wait
for the recovery of the conduction system prior to the
implantation of a permanent PM w4, 5x.
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In this study, complete AV block occurred in 38% (88) of
patients intraoperatively and in the majority of patients
(55%) within one to two days after AVR. The onset for the
AV block appeared in an average time of 1.96 days (range:
one to nine days). In our control group, there was an onset
of transient AV block following AVR that was found to occur
between postoperative days two to five (average of
3.8 days). These findings are in accordance with other
reports in the literature. Keefe et al. reported transient
complete heart block in 18% of patients receiving isolated
AVR w15x.
Given these findings, it appears that the practise of an
early PM implantation is justified after the development of
permanent higher AV block intraoperatively or in the first
24 hours following AVR. A waiting time of two to three days
postoperatively appears to be appropriate, and by following
such an early implantation practise, ICU and hospital stays
and subsequent costs could be reduced.
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